Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma.

Gautschi, Oliver; Menon, Roopika; Bertrand, Miriam; Murer, Christian; Diebold, Joachim

Capmatinib and Osimertinib Combination Therapy for EGFR-Mutant Lung Adenocarcinoma.

Gautschi, Oliver; Menon, Roopika; Bertrand, Miriam; Murer, Christian; Diebold, Joachim.

Afiliación

Gautschi O; Cantonal Hospital Lucerne, Lucerne, Switzerland. Electronic address: oliver.gautschi@luks.ch.
Menon R; NEO New Oncology GmbH, Cologne, Germany.
Bertrand M; NEO New Oncology GmbH, Cologne, Germany.
Murer C; Cantonal Hospital Lucerne, Lucerne, Switzerland.
Diebold J; Cantonal Hospital Lucerne, Lucerne, Switzerland.

J Thorac Oncol ; 15(1): e13-e15, 2020 01.

Article en En | MEDLINE | ID: mdl-31864554

Asunto(s)

Neoplasias Pulmonares; Acrilamidas; Adenocarcinoma del Pulmón/tratamiento farmacológico; Adenocarcinoma del Pulmón/genética; Compuestos de Anilina; Benzamidas; Receptores ErbB/genética; Humanos; Imidazoles; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Mutación; Triazinas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google